JM, F. R., FJ, C., Á, G., J, D., & F, F. (2026). Real-world dosing patterns and outcomes of edoxaban in patients with non-valvular atrial fibrillation and type 2 diabetes mellitus: A gender perspective study. Medicina clinica, 166(9), 107518. https://doi.org/10.1016/j.medcli.2026.107518
Chicago Style (17th ed.) CitationJM, Fernández Rodriguez, Carrasco-Sánchez FJ, González-Franco Á, Diez-Manglano J, and Formiga F. "Real-world Dosing Patterns and Outcomes of Edoxaban in Patients with Non-valvular Atrial Fibrillation and Type 2 Diabetes Mellitus: A Gender Perspective Study." Medicina Clinica 166, no. 9 (2026): 107518. https://doi.org/10.1016/j.medcli.2026.107518.
MLA (9th ed.) CitationJM, Fernández Rodriguez, et al. "Real-world Dosing Patterns and Outcomes of Edoxaban in Patients with Non-valvular Atrial Fibrillation and Type 2 Diabetes Mellitus: A Gender Perspective Study." Medicina Clinica, vol. 166, no. 9, 2026, p. 107518, https://doi.org/10.1016/j.medcli.2026.107518.